Efficacy and safety of the vebreltinib in patients with previously treated, secondary glioblastoma/IDH mutant glioblastoma with PTPRZ1-METFUsion GENe (FUGEN): A randomised, multicentre, open-label, ...
It’s something we’ve been hearing for years, India building its own microcontroller. But most of the time, those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results